1. LBA54IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Barlesi, F; Nishio, M; Cobo, M; Steele, N; Paramonov, V; Parente, B; Dear, R; Berard, H; Peled, N; Seneviratne, L C; Baldini, E; Watanabe, S; Goto, K; Mendus, D; Patel, H; Deng, Y; Kowanetz, M; Hoang, T; Lin, W; Papadimitrakopoulou, V A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗